The store will not work correctly when cookies are disabled.
2,8-dimethyl-5H-pyrido[4,3-b]indol-2-ium iodide
ID: ALA4865927
PubChem CID: 164620546
Max Phase: Preclinical
Molecular Formula: C13H13IN2
Molecular Weight: 197.26
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc2[nH]c3cc[n+](C)cc3c2c1.[I-]
Standard InChI: InChI=1S/C13H12N2.HI/c1-9-3-4-12-10(7-9)11-8-15(2)6-5-13(11)14-12;/h3-8H,1-2H3;1H
Standard InChI Key: SJRRVCFKDUWHBE-UHFFFAOYSA-N
Molfile:
RDKit 2D
16 17 0 0 0 0 0 0 0 0999 V2000
35.4488 -16.1870 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
32.7232 -16.8875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0574 -16.4071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3120 -15.6308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7675 -15.0243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9684 -15.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7167 -15.9732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2628 -16.5764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1237 -15.6310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3772 -16.4047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1724 -16.5708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7150 -15.9640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4568 -15.1885 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.6622 -15.0261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9990 -14.5771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4215 -14.5856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 10 1 0
9 4 1 0
3 2 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
13 15 1 0
6 16 1 0
M CHG 2 1 -1 13 1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 197.26 | Molecular Weight (Monoisotopic): 197.1073 | AlogP: 2.45 | #Rotatable Bonds: ┄ |
Polar Surface Area: 19.67 | Molecular Species: NEUTRAL | HBA: ┄ | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.04 | CX Basic pKa: ┄ | CX LogP: -1.56 | CX LogD: -1.56 |
Aromatic Rings: 3 | Heavy Atoms: 15 | QED Weighted: 0.53 | Np Likeness Score: 0.15 |
References
1. Schwarthoff S, Tischer N, Sager H, Schätz B, Rohrbach MM, Raztsou I, Robaa D, Gaube F, Arndt HD, Winckler T.. (2021) Evaluation of γ-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors., 46 [PMID:34391122] [10.1016/j.bmc.2021.116355] |